Mark Cabling

Aug 14, 2024 | rand.org | Anna Louise |Kevin McGillGERALD HERBERT |Stephen Morris |Mark Cabling

This research was commissioned and fully funded by Pfizer. It was conducted by researchers from RAND Europe and the University of Cambridge. This publication is part of the RAND research report series. Research reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND research reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

Apr 17, 2024 | rand.org | Mark Cabling |Sonja Marjanovic

Cancer is a major global health burden causing 10 million deaths in 2020. In the UK, there are nearly 375,000 new cancer cases per year, almost half caught only at later stages, and only a 50 percent 10-year survival rate. The ability to detect and diagnose cancer earlier and better is a central part of policy efforts to tackle this disease and to improve patient prognosis and outcomes. Blood tests offer hope with better and quicker cancer diagnosis, in the form of liquid biopsy.

Apr 28, 2023 | rand.org | Stephen Morris |Erez Yerushalmi |Robert J. Romanelli |Mark Cabling

The research described in this report was funded by Sanofi and conducted by RAND Europe in collaboration with the University of Cambridge, as the Cambridge Centre for Health Services Research. This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.